CoStar CEO buys $2.5M after stock drops 64% from highs

CoStar's founder just put $2.5M into his own stock. Discretionary. Not a scheduled buy under a 10b5-1 plan. He walked in at $78 per share while CSGP trades 61% below its 52-week high of $97, reached last April. That's the lowest he's paid for his own stock in three years. The buy added 4% to his position, which means he already owned roughly $60M worth before this move. Here's the context that matters.

CoStar reports Q4 earnings April 22. Last quarter they missed estimates by 8.1%. The stock dropped 11% the day after that report and hasn't recovered. Florance founded this company in 1987. He doesn't buy often. When he does, he's betting the market mispriced something. The last time he made an open-market purchase this size was 2020, right before a 340% run over the next two years.

S&P Dow Jones CEO buys $1.1M after 26% drop from highs

Board member Clay dropped $1.1M into SPGI at $426, buying 50% more shares in a discretionary trade. The stock is down 26% from its 52-week high of $579 as the credit rating giant faces regulatory scrutiny over its AI methodology. Her last purchase at similar levels preceded a 40% rally.

SPGI director buys $500K near 52-week low after 26% drop from peak

Board member Moritz dropped $500K into SPGI at $426, doubling his stake in a discretionary buy. The stock is down 26% from its 52-week high as regulatory scrutiny of ratings agencies intensifies. SPGI trades at 45 times earnings while revenue growth has slowed to single digits for the first time since 2020.

Arch Capital director buys $499K near 52-week high amid reinsurance pricing strength

Board member Houston dropped $499K on ACGL shares in the open market at $93.65, a discretionary buy near the middle of the 52-week range. He increased his stake by 35%, a meaningful commitment for a director outside any automated plan. Arch trades at a 10% discount to book value while competitors hover near parity.

IP insider buys $313K near 52-week low amid paper sector rout

Director Scott Tozier just bought $313K of IP at $32, doubling his stake in a discretionary purchase. The stock trades near its 52-week low of $29 after a brutal 43% decline from the peak. Insiders buying at multi-year lows tends to mean something.

ARE CTO buys $144K at multi-year lows, 53% off highs

Board member Thomas Gregory Calvin dropped $144K on ARE shares at $41, just above the 52-week low of $39. Discretionary buy, not pre-planned. The stock is down 53% from its peak as higher rates have crushed REIT valuations, but his timing suggests he sees the bottom forming. Alexandria owns life science real estate in hot biotech hubs where lab space stays sticky even when funding dries up.

HCA issues $1.75B in senior notes to fund operations

HCA Healthcare entered a new credit agreement and issued senior notes totaling several billion dollars while simultaneously repaying existing debt facilities. The refinancing comes as the hospital operator trades near the middle of its 52-week range following a flat year-to-date performance. The move likely extends maturities and potentially lowers borrowing costs while maintaining financial flexibility for capital allocation in a consolidating healthcare services market.

Market Context